Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.
Fount Bio has raised $8.2M in total funding. The most recent round was Series A. The last funding was announced in July 2021.
Fount Bio's investors include Morningside.
Fount Bio is headquartered in Cambridge, United States.
Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.
Fount Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fount Bio — Funding & Investors." VCBacked, July 1, 2021, https://www.vcbacked.co/company/fount-bio. Accessed September 30, 2026.
VCBacked. (2021). Fount Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/fount-bio
{{cite web |title=Fount Bio — Funding & Investors |url=https://www.vcbacked.co/company/fount-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated